News

Monthly obesity shot shows big weight loss in trial
Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...
TCTMD1d
Weight-Loss Drug MariTide Gains Momentum in Phase II Trial
The once-monthly drug is still under study but could provide added convenience and another option for patients.
Scientists find first long-term obesity drug reduces weight
An experimental obesity drug has shown it can “substantially” reduce weight within a year, offering new hope for people with ...
PipelineReview.com2d
Results from Amgen’s phase 2 obesity study of monthly maritide presented at the American Diabetes Association 85th scientific sessions
MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau, and ...
New once-a-month drug could treat diabetes and obesity, scientists say
A new experimental drug meant to be taken just once a month could lead to “substantial weight reduction” within a year and ...
Healio3d
Once-monthly dosing of novel GLP-1 agonist/GIP antagonist yields substantial weight loss
Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...
MedPage Today3d
Novel GLP-1/GIP Agent Led to Weight Loss With Once-Monthly Dosing
CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...